Swiss Health Official Accuses Pharma Industry of 'Rip-offs' and 'Intimidation'
Translated from German, summarized and contextualized by DistantNews.
TLDR
- A senior official from the Swiss Federal Office of Public Health (BAG) publicly accused the pharmaceutical industry of "rip-offs" and "intimidation tactics."
- The official, Jรถrg Indermitte, criticized the industry's lobbying and pricing strategies during a presentation at a conference sponsored by the industry.
- The remarks have caused a stir, with some criticizing the official's tone as politically clumsy and un-Swiss, while others suggest the BAG has a left-leaning, industry-hostile bias.
A senior official from Switzerland's Federal Office of Public Health (BAG), Jรถrg Indermitte, has publicly lambasted the pharmaceutical industry, accusing it of "rip-offs," "intimidation tactics," and "fear-mongering." This unprecedented outburst occurred during a presentation at the Health Insurance Days conference in Interlaken, an event notably sponsored by the very industry Indermitte attacked. The official's use of strong language, including "Do you want to sell us as fools?", has sent shockwaves through the sector and sparked a debate about the relationship between the state and one of Switzerland's most vital export industries.
Wollt ihr uns fรผr dumm verkaufen?
Indermitte, who heads the BAG's medicines division, did not hold back, criticizing the industry's "intensive lobbying" and "lack of transparency." His remarks, delivered with the official BAG logo displayed, have been described as "politically clumsy" and "not role-compliant" by health experts like Felix Schneuwly. Schneuwly, an expert at Comparis, emphasized that such a public attack by a federal official on a key economic pillar is "un-Swiss," suggesting that conflicts are typically resolved through partnership.
Das geht so nicht. Dieser Auftritt war nicht rollenkonform
This incident also brings to the fore long-standing criticisms of the BAG itself. Thomas de Courten, a national councilor from the Swiss People's Party (SVP), echoed sentiments that the BAG is "dyed in the wool red" and suffers from "ideological blinders." He argues that the office fails to grasp the dynamics of the booming pharmaceutical sector, exhibiting a politically one-sided, left-leaning, and market-detached perspective. The confrontation highlights a deep-seated tension between regulatory oversight and the economic interests of a powerful industry, with the Swiss public likely to be watching closely how this high-stakes conflict unfolds.
Das ist unschweizerisch. Wir lรถsen Konflikte in der Regel partnerschaftlich.
Originally published by Neue Zรผrcher Zeitung in German. Translated, summarized, and contextualized by our editorial team with added local perspective. Read our editorial standards.